Kathleen Kahler Fonda

Array ( [id] => 3658970 [patent_doc_number] => 05623064 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Poly-.beta.-1.fwdarw.-4-N-acetylglucosamine' [patent_app_type] => 1 [patent_app_number] => 8/347911 [patent_app_country] => US [patent_app_date] => 1994-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 71 [patent_no_of_words] => 28975 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/623/05623064.pdf [firstpage_image] =>[orig_patent_app_number] => 347911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3691727 [patent_doc_number] => 05604207 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'Sialyl Le.sup.x analogues as inhibitors of cellular adhesion' [patent_app_type] => 1 [patent_app_number] => 8/345072 [patent_app_country] => US [patent_app_date] => 1994-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32959 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 259 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/604/05604207.pdf [firstpage_image] =>[orig_patent_app_number] => 345072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3578087 [patent_doc_number] => 05490978 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-13 [patent_title] => 'Block copolymers of polysaccharides and polyalkylene oxides' [patent_app_type] => 1 [patent_app_number] => 8/345286 [patent_app_country] => US [patent_app_date] => 1994-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5784 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/490/05490978.pdf [firstpage_image] =>[orig_patent_app_number] => 345286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3581328 [patent_doc_number] => 05498604 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-12 [patent_title] => 'Lewis-type sugar chain derivative' [patent_app_type] => 1 [patent_app_number] => 8/256991 [patent_app_country] => US [patent_app_date] => 1994-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12891 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/498/05498604.pdf [firstpage_image] =>[orig_patent_app_number] => 256991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3628375 [patent_doc_number] => 05686426 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/340951 [patent_app_country] => US [patent_app_date] => 1994-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53422 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686426.pdf [firstpage_image] =>[orig_patent_app_number] => 340951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1474945 [patent_doc_number] => 06387884 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Leukocyte homing modulation' [patent_app_type] => B1 [patent_app_number] => 08/336417 [patent_app_country] => US [patent_app_date] => 1994-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5203 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387884.pdf [firstpage_image] =>[orig_patent_app_number] => 08336417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459903 [patent_doc_number] => 06391857 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Methods and compositions for endothelial binding' [patent_app_type] => B1 [patent_app_number] => 08/336466 [patent_app_country] => US [patent_app_date] => 1994-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6237 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391857.pdf [firstpage_image] =>[orig_patent_app_number] => 08336466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728845 [patent_doc_number] => 05652221 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Method of treating defective glucose metabolism using synthetic insulin substances' [patent_app_type] => 1 [patent_app_number] => 8/335015 [patent_app_country] => US [patent_app_date] => 1994-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2813 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652221.pdf [firstpage_image] =>[orig_patent_app_number] => 335015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3582261 [patent_doc_number] => 05580858 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'Immunosuppressive and tolerogenic modified Lewis.sup.x compounds' [patent_app_type] => 1 [patent_app_number] => 8/337461 [patent_app_country] => US [patent_app_date] => 1994-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 29333 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580858.pdf [firstpage_image] =>[orig_patent_app_number] => 337461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3526446 [patent_doc_number] => 05541167 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-30 [patent_title] => 'Thromboresistant coating for defoaming applications' [patent_app_type] => 1 [patent_app_number] => 8/331292 [patent_app_country] => US [patent_app_date] => 1994-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2739 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/541/05541167.pdf [firstpage_image] =>[orig_patent_app_number] => 331292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3829052 [patent_doc_number] => 05739115 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'Sulfated maltooligosaccharides with heparin-like properties' [patent_app_type] => 1 [patent_app_number] => 8/312571 [patent_app_country] => US [patent_app_date] => 1994-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 8389 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/739/05739115.pdf [firstpage_image] =>[orig_patent_app_number] => 312571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4028074 [patent_doc_number] => 05902795 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-11 [patent_title] => 'Oligosaccharides reactive with hyaluronan-binding protein and their methods of use' [patent_app_type] => 1 [patent_app_number] => 8/306150 [patent_app_country] => US [patent_app_date] => 1994-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 26 [patent_no_of_words] => 11218 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/902/05902795.pdf [firstpage_image] =>[orig_patent_app_number] => 306150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590259 [patent_doc_number] => 05567684 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-22 [patent_title] => 'Synthetic ganglioside derivatives' [patent_app_type] => 1 [patent_app_number] => 8/305832 [patent_app_country] => US [patent_app_date] => 1994-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 8659 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/567/05567684.pdf [firstpage_image] =>[orig_patent_app_number] => 305832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3815564 [patent_doc_number] => 05710268 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Process for the preparation of methylated cyclodextrin derivatives, and their use as solubilizers' [patent_app_type] => 1 [patent_app_number] => 8/308376 [patent_app_country] => US [patent_app_date] => 1994-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3503 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710268.pdf [firstpage_image] =>[orig_patent_app_number] => 308376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1303484 [patent_doc_number] => 06620792 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-16 [patent_title] => 'Pharmaceutical compositions containing monosialoganglioside GM1 or derivative thereof suitable for the treatment of parkinson\'s disease' [patent_app_type] => B1 [patent_app_number] => 08/304391 [patent_app_country] => US [patent_app_date] => 1994-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 5667 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620792.pdf [firstpage_image] =>[orig_patent_app_number] => 08304391 [rel_patent_id] =>[rel_patent_doc_number] =>)